Acadia Healthcare Q2 2026: Beds, Cash Flow, and an EPS Dip

Overview: A quarter of headway and headwinds in equal measure

The quarter ends June 30, 2026, and Acadia Healthcare Company, Inc. (ACHC) served up a narrative that is part operational steadiness, part accounting stutter. Revenue came in around $865.8 million—essentially flat versus the prior year’s second quarter—while GAAP net income dropped to $10.9 million, or about $0.12 per diluted share. The per-share picture improves when you strip out items the company calls non-GAAP: adjusted net income was $35.1 million, or $0.38 per diluted share, down meaningfully from $74.8 million or $0.83 in the prior-year period. In other words, what you see depends on whether you’re measuring with GAAP tape or the company’s finish-line markers.

The release emphasizes that Adjusted EBITDA was $149.2 million, reflecting a $28.6 million adjustment to professional and general liability reserves, partially offset by a $26.1 million benefit tied to the Florida supplemental payment program and provider tax adjustments. The delta between GAAP and Adjusted metrics is a reminder that the health-care services business accrues a lot of one-off and policy-driven items into the earnings narrative.

Financial highlights at a glance

• Revenue: $865.8 million; flat vs. Q2 2025; growth in the quarter was 2.8% after normalizing prior period supplemental program revenue.
• Net income attributable to Acadia: $10.9 million, or $0.12 per diluted share (GAAP).
• Adjusted net income attributable to Acadia: $35.1 million, or $0.38 per diluted share (non-GAAP).
• Adjusted EBITDA: $149.2 million; includes a $28.6 million PLGL reserve adjustment; offset by a $26.1 million Florida program/ provider tax benefit.
• Operating cash flow: $162.1 million, up from $133.5 million in the prior year.
• Capital expenditures: $38.6 million, far below the prior-year period’s $167.7 million.
• Bed additions: Added 240 licensed beds during the quarter from newly constructed facilities.

What management said (and what it means)

CEO commentary touts progress on key priorities: opening two new facilities with joint-venture partners, ramping occupancy at newer facilities, and maintaining strong free cash flow. The rhetoric is purposeful, focusing on expansion and operating discipline. The earnings narrative, however, turns on a mix of temporary offsets and longer-term structural shifts. The Florida supplemental payment program and provider tax adjustments underscore how policy environments and settlement mechanics can swing Adjusted EBITDA, sometimes masking underlying operational momentum.

From a numbers perspective, the GAAP vs. non-GAAP delta matters. A $28.6 million hit to reserves for PLGL (professional and general liability) risks raising questions about future reserve sensitivity, while the $26.1 million Florida boost provides a reminder that policy-related cash inflows can distort clean trend analysis. The result is a company that looks robust on cash generation but has a more modest earnings cadence when you strip out one-time adjustments.

Guidance and the revenue forecast for the back half

Acadia reiterates that it provided full-year 2026 financial and cash-flow guidance, signaling that management expects continued operating discipline and capital deployment to remain the core driver of value. The press release does not publish a detailed revenue forecast or EPS consensus in the snippet, but the emphasis on cash flow, free cash flow, and ongoing capex discipline suggests a cautiously constructive stance for the remainder of 2026. Investors will be weighing the absence of a precise top-line target against the company’s ability to translate occupancy and patient days into sustainable cash flow and strategic bed growth.

Implications for ACHC and sector peers

Acadia’s quarter reinforces a broader theme in behavioral-health real assets: growth is increasingly funded by cash flow efficiency and portfolio expansion rather than purely by price leverage or volume surges. The added 240 beds and two JV-driven facilities point to a deployment strategy that favors scale and geographic diversification, albeit with the usual policy and reimbursement sensitivities. For peers, the message is clear: the capacity race continues, but the margin path will hinge on how well operators manage one-off reserve movements and the variability of state-level supplemental programs and taxes.

In terms of market signals, the absence of a concrete revenue forecast in the release could keep EPS consensus and equity multiple conversations anchored to how well facilities sustain occupancy and how regulatory changes (like Florida’s supplemental program dynamics) affect margins. The sector’s next leg may hinge on how effectively players convert cash flow gains into modest, durable earnings growth, a shift away from short-term haircut-style adjustments toward steadier, cash-driven expansion.

Risks and caveats to watch

Non-GAAP metrics provide flexibility, but they also invite scrutiny about what gets included or excluded. The PLGL reserve adjustment and Florida-related benefits illustrate how accounting choices and policy arrangements can move the earnings narrative. Investors should watch for more granularity on the long-term revenue trajectory, the sustainability of adjusted EBITDA margins, and any further bed additions versus capital spend discipline. As always, regulatory developments and payer mix will influence the earnings surprise risk profile across ACHC and its peers.

Bottom line: what to take away

Acadia delivered cash-flow resilience in a quarter marked by meaningful one-off adjustments. The GAAP EPS dip contrasts with stronger cash flow and a strategic expansion program, including new facilities and 240 beds added in the period. While the year remains uncertain in terms of precise revenue targets, the company’s emphasis on disciplined capital allocation and free cash flow generation positions ACHC to weather policy crosswinds and pursue growth opportunities. For investors watching ACHC in the context of peers, the key narrative is about how durable the cash flow engine can be as hospitals and behavioral-health providers continue to balance growth with reimbursement realities.